Sort
40,608 grants matching “prostate cancer”
Molecular mechanisms specific to ETS transcription factors that drive oncogenesis
$464,469Peter Celestine Hollenhorst · Indiana University Indianapolis · R01 · FY2021 · CA
Mechanisms of targeting cellular self-renewal in glioblastoma
$464,444Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
$464,405Laurence H Baker · University Of Michigan At Ann Arbor · U10 · FY2008 · CA
Phase I Clinical Trials of Novel Agents
$464,385Naiyer A Rizvi · Sloan-Kettering Inst Can Research · U01 · FY2007 · CA
Molecular mechanisms of prostate cancer metastasis
$464,375Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2022 · CA
Molecular mechanisms of prostate cancer metastasis
$464,375Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2023 · CA
Steroid Hormone Genes and Ovarian Cancer Risk
$464,332Mary Anne Rossing · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Elevated homocysteine in African American Prostate Cancer: Association with Diet and Dietary practices, evaluating its biomarker potential, and characterizing its tumor promoting function
$464,326Arun Sreekumar · Baylor College Of Medicine · R01 · FY2025 · CA
Elevated homocysteine in African American Prostate Cancer: Association with Diet and Dietary practices, evaluating its biomarker potential, and characterizing its tumor promoting function
$464,326Arun Sreekumar · Baylor College Of Medicine · R01 · FY2022 · CA
Exploring Collateral Lethality for Development of Cancer Therapeutics
$464,312Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Rational in situ programming of cancer vaccine-responding T-cell clones
$464,178Matthias Stephan · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Construction of the Androgen Receptor Interactome: A Molecular Framework for Probing Genetic Interactions in Androgen-Dependent Signaling
$464,176Michael E Wright · University Of Iowa · R01 · FY2021 · GM
Tissue/Informatics Core
$464,174Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2011 · CA
Imaging Feedback to Guide Ultrasonic Tissue Fractionation for Cancer Therapy
$464,137Charles Alan Cain · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer
$464,108Natasha Kyprianou · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Community-based Navigator Program for Cancer Control in African Americans
$464,107Jerry Calvin Johnson · University Of Pennsylvania · R01 · FY2012 · CA
Identification of Novel Alpha Amidated Peptide Hormones
$464,050Angelo P Consalvo · Unigene Laboratories, Inc. · R44 · FY2007 · DK
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$464,033Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Increasing nerve-sparing radical prostatectomy rates using intraoperative nonlinear microscopy
$463,983James G Fujimoto · Massachusetts Institute Of Technology · R01 · FY2023 · CA
Real time fine needle assessment of architectural heterogeneity in prostate cancer
$463,964Guan Xu · University Of Michigan At Ann Arbor · R37 · FY2025 · CA
Transgenic Animal Models for Prostate Cancer
$463,937Robert J Matusik · Vanderbilt University · R01 · FY2006 · CA
NCCU-BBRI/UNC-LINEBERGER PARTNERSHIP IN CANCER RESEARCH
$463,886North Carolina Central University · U56 · FY2002 · CA
Nanotechnology enabled targeting of p53 deficiency in human cancer
$463,867Xiaoming He · Univ Of Maryland, College Park · R01 · FY2020 · CA
Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancer
$463,861Jong Y Park · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers
$463,832Sigrid Carlsson · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA